Logo

Genedata Expands Serono Deal by Integrating Software With Cellomics Tech

Dec 13, 2006
NEW YORK (GenomeWeb News) — Genedata today said it has expanded a research collaboration with Serono that uses Genedata’s Screener software with high-content screening assays.
 
Serono began using Genedata's software in 2003. Genedata said that the expanded agreement will integrate Screener with high-content screening technology from Cellomics. It will also add an application-programming interface to the software to enable it to integrate with additional software applications.
 
Genedata said the agreement will help Serono more efficiently analyze and annotate the results of their screenings.
 
Financial terms of the agreement were not disclosed.

Filed under

Informatics
Breaking News
The Scan

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.